Metraipolis › archive › dc_d67bc95ddc91
Real-World Outcomes of Hypomethylating Agents for Higher-Risk Myelodysplastic Syndromes: Report From the Nationwide Multicenter Thai MDS Study — Europe PMC PMID:42746080
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42746080
- DOI
- 10.1155/ah/2732324
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T13:14:06.847Z
- SHA-256 of the archived text
4781f35a08bd98795d9b8a6f40ebe44922ebb028f911dd42893c8e4b2e1532a2- Stable URL of this page
https://metraipolis.com/documento/dc_d67bc95ddc91
How to cite
Real-World Outcomes of Hypomethylating Agents for Higher-Risk Myelodysplastic Syndromes: Report From the Nationwide Multicenter Thai MDS Study — Europe PMC PMID:42746080 — Europe PMC (en), https://europepmc.org/article/MED/42746080 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d67bc95ddc91 (Metraipolis archive dc_d67bc95ddc91, sha256 4781f35a08bd98795d9b8a6f40ebe44922ebb028f911dd42893c8e4b2e1532a2)
BibTeX
@misc{dcd67bc95ddc91,
title = {Real-World Outcomes of Hypomethylating Agents for Higher-Risk Myelodysplastic Syndromes: Report From the Nationwide Multicenter Thai MDS Study — Europe PMC PMID:42746080},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42746080},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d67bc95ddc91; sha256 4781f35a08bd98795d9b8a6f40ebe44922ebb028f911dd42893c8e4b2e1532a2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42746080. Agents can read the archived copy with the MCP tool read_document.